Charles Perou is a Professor of Genetics at the University of North Carolina at Chapel Hill since November 2000. In addition to this role, Charles co-founded and serves as a consultant for Reveal Genomics, S.L. since January 2020, and is a co-founder and board member at GeneCentric Therapeutics, Inc., since June 2011. Charles Perou completed a postdoctoral fellowship in Genetics at Stanford University School of Medicine from August 1997 to November 2000, and earned a PhD in Pathology/Experimental Pathology from the University of Utah from September 1989 to July 1997. Charles also holds a Bachelor of Science degree from Bates College, obtained in May 1987.